MedWatch

FDA approves new Ambu product

A novel product from Ambu which combines a single-use bronchoscope with a sampling system has been approved by the FDA today, Monday.

Photo: Ambu PR

Ambu can now launch a new piece of equipment on the US market. The US Food and Drug Authority (FDA) has approved Ambu's newest product, Ascope 4 Broncho Sampler Set. The 510(k) clearance allows for the launch of this product which performs specific procedures in the respiratory system of patients while taking samples using the same device.

"We've seen a distinct need for a simple, all-in-one solution for certain types of procedures where clinicians need to clear the airways of a patient or take fluid samples from the lungs," says Ambu Chief Marketing Officer Bassel Rifai in a press release.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs